Peritoneal dialysis system and methods

Information

  • Patent Grant
  • 11951241
  • Patent Number
    11,951,241
  • Date Filed
    Monday, November 28, 2022
    2 years ago
  • Date Issued
    Tuesday, April 9, 2024
    8 months ago
Abstract
Described herein are systems and methods for performing peritoneal dialysis. According to one aspect, the disclosure provides a sterile interface connection for connecting a water purification system to a disposable source of dialysate concentrates. The sterile interface connection can include a chamber comprising an inlet adapted to be connected to the water purification system on a proximal end and a valve on a distal end. The sterile interface connection can also include spring-loaded needle disposed in the chamber. The spring-loaded needle can move between a retracted configuration in which the spring-loaded needle is fully retracted into the chamber and the valve is closed and sealed, and an extended configuration in which the spring-loaded needle extends through the valve into the disposable source of dialysate concentrates.
Description
FIELD

This disclosure generally relates to dialysis systems. More specifically, this disclosure relates to peritoneal dialysis systems that include many features that reduce the need for disposables storage by using on-demand water and making setup and delivery easier for the patient.


BACKGROUND

There are, at present, hundreds of thousands of patients in the United States with end-stage renal disease. Most of those require dialysis to survive. Many patients receive hemodialysis treatment at a dialysis center, which can place a demanding, restrictive and tiring schedule on a patient. Patients who receive in-center dialysis typically must travel to the center at least three times a week and sit in a chair for 3 to 4 hours each time while toxins and excess fluids are filtered from their blood. After the treatment, the patient must wait for the needle site to stop bleeding and blood pressure to return to normal, which requires even more time taken away from other, more fulfilling activities in their daily lives. Moreover, in-center patients must follow an uncompromising schedule as a typical center treats three to five shifts of patients in the course of a day. As a result, many people who dialyze three times a week complain of feeling exhausted for at least a few hours after a session.


Peritoneal dialysis provides an alternative to hemodialysis in which fluid is introduced into the peritoneum through a permanent tube in the abdomen. Peritoneal dialysis is typically performed in a patient's home while the patient sleeps. The main complication from peritoneal dialysis is infection of the abdomen through the permanent tube.


Traditional peritoneal dialysis requires the batch preparation of fluid that is terminally sterilized before being consumed by the patient. In addition, traditional peritoneal dialysis systems require the patient to make numerous fluid connections. This batch preparation of fluid and numerous setup steps makes treatment in the home difficult.


SUMMARY

Described herein are apparatus including a sterile interface connection configured to connect a water purification system to a disposable source of dialysate concentrates, the sterile interface connection comprising a chamber comprising an inlet adapted to be connected to the water purification system on a proximal end and a valve on a distal end, a spring-loaded needle disposed in the chamber, a proximal end of the spring-loaded needle being connected to the inlet, wherein the sterile interface connection includes a retracted configuration in which the spring-loaded needle is fully retracted into the chamber and the valve is closed and sealed, the sterile interface connection further including an extended configuration in which the spring-loaded needle extends through the valve into the disposable source of dialysate concentrates.


The spring-loaded needle may further include a lumen extending therethrough and a port disposed at a distal end of the spring-loaded needle. The spring-loaded needle may also be configured to deliver water from the water purification system to the disposable source of dialysate concentrates.


The chamber may further comprise an outlet, the sterile interface connection being configured to, in the retracted position, receive fluid from the water purification system via the inlet to sterilize the chamber and the spring-loaded needle and discard the fluid through the outlet. The fluid may be configured to contact all interior and exterior surfaces of the spring-loaded needle.


Described herein are apparatus including a sterile interface connection of a disposable source of dialysate concentrates, the sterile interface connection being configured to receive a needle of a water purification system to mate the water purification system to the disposable source of dialysate concentrates, the sterile interface connection comprising an alignment feature adapted to guide the needle into the sterile interface connection, a disinfectant plug adjacent to the alignment feature, the disinfectant plug being configured to sterilize the needle as it passes through the disinfectant plug, and a sealing septum adjacent to the disinfectant plug, the sealing septum adapted to form a seal around the needle when the needle punctures the sealing septum.


The interface connection can include a sterile seal disposed over the disinfectant plug, wherein the sterile seal is to be removed from the sterile interface connection prior to needle entry.


Described herein are methods, including a method of connecting a water purification system to a disposable source of dialysate concentrates, comprising receiving a sterile interface connection comprising a chamber, a spring-loaded needle disposed in the chamber, and a valve of the chamber that is closed and sealed, connecting an inlet of the sterile interface connection to the water purification system, extending the spring-loaded needle through the valve into the disposable source of dialysate concentrates.


Any of the methods may further comprise delivering fluid from the water purification system to the disposable source of dialysate concentrates through the sterile interface connection.


Any of the methods may further comprise receiving fluid from the water purification system via an inlet in the sterile interface connection to sterilize the chamber and the spring-loaded needle. Additionally, the methods may include discarding the fluid through an outlet of the sterile interface connection. The fluid can contact all interior and exterior surfaces of the spring-loaded needle.





BRIEF DESCRIPTION OF THE DRAWINGS

The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:



FIG. 1 illustrates one embodiment of a peritoneal dialysis system.



FIG. 2 shows a schematic diagram of the water purification system 102 of FIG. 1.



FIG. 3 shows a schematic diagram of an alternate water purification system that uses de-ionization technology to remove ionic impurities prior to the ultrafilter.



FIG. 4 illustrates a reusable portion of a sterile interface connection that bridges the water purification system to the disposable consumable.



FIGS. 5 and 6 show a disposable portion of the sterile interface connection that bridges the water purification system to the disposable consumable.



FIG. 7 illustrates a concentrate container that contains pre-sterilized dialysate concentrates proportioned to the appropriate dosage for treatment.



FIG. 8 illustrates an automated cycler of a peritoneal dialysis system which feeds the dialysis solution to and from the patient's peritoneum.



FIG. 9 shows an automated cycler that incorporates a dialyzer.



FIG. 10 shows one example of a sterile vessel.





DETAILED DESCRIPTION

This disclosure describes systems, devices, and methods related to peritoneal dialysis therapy. In some embodiments, the peritoneal dialysis system can be a home dialysis system. Embodiments of the dialysis system can include various features that automate and improve the performance, efficiency, and safety of dialysis therapy.


In some embodiments, a dialysis system is described that can provide acute and chronic peritoneal dialysis therapy to users. The system can include a water purification system configured to prepare water for use in dialysis therapy in real-time using available water sources, and a disposable consumable that interfaces with the water purification system to produce dialysate for dialysis therapy.


In some embodiments, a peritoneal dialysis system can prepare substantially sterile water in real-time for creating dialysis solution. The peritoneal dialysis systems described can also include features that make it easy for a patient to self-administer therapy. For example, a disposable consumable with minimal connection points can be easily installed for automated mixing and movement of fluids. Methods of use are also provided, including real-time dialysis solution monitoring, recirculation of dialysis solutions, and interface connections.



FIG. 1 illustrates one embodiment of a peritoneal dialysis system 100 configured to provide dialysis treatment to a user in either a clinical or non-clinical setting, such as the user's home. The dialysis system 100 can comprise a sterile water system 102 connected to a disposable consumable 104. The disposable consumable 104 can interface with a catheter in the abdomen of the patient 106. Both the sterile water system and the disposable consumable can be connected to a drain 106.


The water purification system 102 can be configured to purify a water source in real-time for dialysis therapy. For example, the water purification system can be connected to a residential water source (e.g., tap water) and prepare pasteurized water in real-time. The pasteurized water can then be used for peritoneal dialysis therapy without the need to heat and cool large batched quantities of water typically associated with water purification methodologies.



FIG. 2 shows a schematic diagram of the water purification system 102 of FIG. 1. The water purification system can include a source of incoming water 110 (e.g., a tap), one or more sediment filter(s) 112, carbon filter(s) 114, reverse-osmosis (RO) membrane(s) 116, ultrafilter(s) 118, and a heat exchanger (HEX) 120.


The source of incoming water 110 provides supply water to the water purification system, which passes through the sediment filter(s) 112 to filter out particulates in the fluid.


Next, the fluid passes through the carbon filter(s) 114 to filter toxins such as chlorine and chloramine. In some embodiments, there could be multiple carbon filters to ensure that chlorine and chloramine levels are within acceptable range for downstream components.


The fluid then passes through the RO membranes 116 which reject ions in the fluid. A preferred rejection ratio of the RO membranes can be at least 94%. In other embodiments, the rejection ratio can be at least 90%. The permeate water continues toward the ultrafilter 118, while the concentrated ions removed from the fluid by the RO membranes are directed to the drain 108. In some embodiments, there can be a plurality of RO membranes to maximize permeate water retention.


As the permeate water traverses across the ultrafilter(s) 118, any bacteria or endotoxins adhere to the ultrafilter(s). In one specific embodiment, the ultrafilter can be a polysulfone membrane with a pore size of at least 0.01 microns. In some embodiments, there can be several ultrafilters in series to ensure water purity. In other embodiments, the ultrafilter(s) may be located at other points in the fluid path, including before the RO membranes.


Finally, the permeate water is passed through a pasteurization system or HEX 120, that uses elevated pressures and temperatures to denatured and inactivate all the endotoxins in the permeate water. It has been shown that elevating endotoxin to a temperature above 200 C at a pressure of 240 PSI can provide more than a log 2 reduction in endotoxin level.



FIG. 3 shows a schematic diagram of an alternate water purification system that uses de-ionization technology to remove ionic impurities prior to the ultrafilter. Instead of using RO membranes before the ultrafilter as in the embodiment of FIG. 2, the water purification system 102 of FIG. 3 incorporates one or more de-ionizing resin(s) 122 to capture undesired ions and output pure water.


Once sterile water device reaches temperature and pressure conditions in which endotoxins and bacteria are actively denatured and inactivated, the water can be directed from the water purification system to the disposable consumable. The disposable consumable can include a number of features, described below.


In another embodiment, the sterile water coming from the water purification system can be stored into a sterile vessel. The vessel can be self-disinfectable from water produced by the heat exchanger, and may contain actuator elements to circulate fluid within itself to prevent dead volumes from occurring. In some embodiments, the sterile vessel may be one open volume, wherein contained fluid may be periodically or continuously agitated by one or a plurality of rotary mixers. In one embodiment, as shown in FIG. 10, a sterile vessel 1000 may comprise a substantially non-branched fluid path 1052 arranged in a serpentine configuration, or other configuration which allows for a long linear path length in a small volume. One or more circulation pumps 1054 disposed within the fluid paths cause the fluid to circulate. The inlet 1056 and outlet 1058 of the fluid path may be controllably opened by valves 1060 to allow water in and out of the fluid path. Sterile water emerging from the vessel can then be mixed with the contents of the concentrate container in a homogenous fashion, and be raised to patient temperature.



FIGS. 4-6 illustrate a reusable portion of a sterile interface connection that bridges the water purification system to the disposable consumable. The sterile interface connection can include a reusable connection 124 on the water purification system, and a disposable connection 125 on the disposable consumable. The chances for contamination in the peritoneal dialysis system are limited by having only one interface between the disposable consumable and the water purification system.


Referring to FIG. 4, the reusable connection 124 can include a chamber 126, a spring loaded needle 128, a chamber outlet 130, and a self-opening and self-sealing door 132. The reusable connection 124 can include a retracted configuration and an extended configuration. In the retracted configuration, the spring loaded needle 128 can be retracted into the chamber 126 through the door 132 to limit exposure to the ambient environment. In this retracted position, the water purification system can to rinse the interface with disinfectant, sterile water, or a combination of the two. In the extended configuration, the spring loaded needle 128 can extend through the door 132 to puncture or be inserted into the disposable consumable.


Referring to FIGS. 5-6, the disposable connection 125 of the sterile interface connection can have a puncture point that is be pre-sterilized until active use. The puncture point can be manually exposed or automatically exposed prior to active use. In one embodiment, referring to FIG. 5, the puncture point of the disposable connection 125 may include an alignment feature 134 configured to guide needle 128 into the puncture point. In the illustrated embodiment, the puncture point can include a disinfectant plug 136 and a sealing septum 138. The sealing septum can comprise an elastomer or similar material. Upon needle puncture, the sealing septum 138 can form a seal around the needle 128, thereby creating a non-leaking connection between the sterile water system and the disposable.


In another embodiment, referring to FIG. 6, the puncture point can be covered with a sterile seal 140 that is removable by the user prior to active use. Peeling the removable seal may be manual or automatic in nature, but sterility of the puncture point can be maintained.


Systems and methods are also provided for the creation, disposal, and recycling of dialysate solution prior to, during, and after treatment.


Referring to FIG. 7, the disposable consumable can include a concentrate container 142 that contains pre-sterilized dialysate concentrates proportioned to the appropriate dosage for treatment. In one embodiment, the concentrate container can include acid powder, bicarb powder, glucose, and other concentrates. In some embodiments, these concentrates can be used to produce the oncotic or osmotic gradient required for conducting peritoneal dialysis. In some embodiments, these concentrates may contain high molecular weight substances such as polysaccharide, polyamides or polypeptides in order to minimize transfer of these substances into the patient. Over the course of a typical overnight peritoneal dialysis session, several infusion/drain cycles may be performed, wherein the peritoneal dialysis fluid is infused into the patient's peritoneum, allowed to dwell, and drained. Because there a plurality of concentrates available, the composition of the dialysis fluid infused for each cycle may be varied, for example, to achieve different clinical goals, such as increased fluid removal, minimization of glucose retention, or maintenance of nutritional compounds that may be lost during the drain cycle. In some embodiments, the disposable consumable may have electrodes built into it, connectable to an external sensor for real-time dialysis fluid monitoring.


Sterile water coming from the water purification system can be mixed with the contents of the concentrate container in a homogenous fashion, and be raised to patient temperature. In some embodiments, the disposable consumable comprises two thin, thermally conductive, flexible sheets welded together in a pattern to produce tortuous flow paths that promote mixing of fluids. The disposable consumable may further comprise tubing sections, or other features which can be acted upon by non fluid-contacting pumps on the durable portion of the invention. Temperature, conductivity or other properties of the fluid within the disposable consumable may be sensed or measured by non-contact sensors connected to the durable portion of the invention. Heat may also be applied to the fluid in the disposable consumable through at least one side of the thin, thermally conductive flexible sheets.


Once fully mixed, the dialysis solution could then be routed to a patient with an automated cycler, thereby enabling real-time peritoneal dialysis solution generation and delivery. The benefit of real-time peritoneal dialysis solution generation during automated peritoneal dialysis is such that the patient does not have to make multiple connections from multiple sources, thus increasing the risk of peritonitis. Furthermore, the use of batch prepared dialysis solution can be burdensome for the patient, as bags containing liters of solution are relatively heavy for the typical dialysis patient. This system minimizes intense physical activity for the patient prior to initiating a treatment.


In another embodiment, the fully mixed dialysis solution could then be routed to a sterile dialysis fluid vessel via an automated cycler. This would enable batching of the peritoneal dialysis solution prior to delivery.



FIG. 8 illustrates an automated cycler 144 of the disposable consumable of a peritoneal dialysis system, which feeds the dialysis solution to and from the patient's peritoneum. The automated cycler 144 can contain all of the non-contact pumps and sensors that interact with the dialysate solution to deliver the solution to the patient. When the spring loaded needle of the reusable connection is connected to the disposable connection, as described above, the internal concentrate lines 146 can be opened. Pumps of the automated cycler, such as peristaltic pumps, can be used to pump supersaturated mixtures of each concentrate into a mixing chamber 148. The fluid within the mixing chamber can then be elevated to the patient temperature.


As proportioning of the dialysis solution is critical, a conductivity sensor will mate to the electrical leads of the disposable consumable to allow the cycler to monitor the quality of the dialysis fluid in real-time. Should the dialysis fluid not meet the settings prescribed on the prescription, the cycler will be able to route the fluid to drain until proportioning is corrected. The conductivity sensor can be placed, for example, at an outlet of the mixing chamber.


As extreme nutrient loss is extremely prevalent in peritoneal dialysis, it may be desirable to recycle the patient effluent dialysis solution as to prevent critical proteins from leaving the body. Referring to FIG. 9, the automated cycler 144 can incorporate a dialyzer 146 that allows for the diffusion or convection of waste from one fluid source to another. In this embodiment, the dialysis solution side of the dialyzer can be constantly be replenished with new dialysis solution flowing in one direction, while the patient effluent solution side of the dialyzer can move fluid in the opposite direction as to maximize waste clearances. The dialyzer may also be bypassed, in events for filling or draining the peritoneum.


As peritonitis is a common, yet unexpected, outcome of peritoneal dialysis, early detection of peritonitis symptoms can be detected through the constant monitoring of drain line. In particular, a turbidity meter to monitor patient effluent can be placed in or around the drain line to monitor the change in discoloration of the fluid. Once detected, the automated cycler can alarm the user of the onset of peritonitis and take appropriate action.

Claims
  • 1. A disposable consumable container configured to produce dialysate solution in real-time, comprising: a sterile interface connection on the disposable consumable container and configured to be fluidly coupled to a source of sterile water;a concentrate container for coupling to the source of sterile water via the sterile interface connection and containing a plurality of pre-sterilized dialysate concentrates;a mixing chamber configured to promote mixing of sterile water with the plurality of pre-sterilized dialysate concentrates to produce dialysis fluid; andan automated cycler configured to pump mixtures of each of the plurality of pre-sterilized dialysate concentrates into the mixing chamber, the automated cycler being further configured to feed the produced dialysis fluid to and from a patient.
  • 2. The disposable consumable container of claim 1, wherein the mixing chamber is configured to elevate fluid within the mixing chamber to patient temperature.
  • 3. The disposable consumable container of claim 1, wherein the mixing chamber comprises a plurality of thermally conductive, flexible sheets welded together in a pattern to produce tortuous flow paths that promote mixing and heating of the sterile water with the dialysate concentrates.
  • 4. The disposable consumable container of claim 1, further comprising tubing sections which may be acted upon by pumps of the automated cycler.
  • 5. The disposable consumable container of claim 1, further comprising one or more sensors configured to measure properties of the dialysis fluid.
  • 6. The disposable consumable container of claim 1, further comprising a conductivity sensor configured to monitor a quality of the dialysis fluid in real time.
  • 7. The disposable consumable container of claim 6, wherein the automated cycler is configured to route the dialysis fluid to a drain if the dialysis fluid does not meet prescribed settings.
  • 8. The disposable consumable container of claim 6, wherein the conductivity sensor is placed at an outlet of the mixing chamber.
  • 9. The disposable consumable container of claim 1, wherein the automated cycler further includes a dialyzer that allows for diffusion or convection of waste from a first fluid to a second fluid.
  • 10. The disposable consumable container of claim 9, wherein the first fluid comprises the dialysis fluid and the second fluid comprises a patient effluent solution.
  • 11. The disposable consumable container of claim 10, wherein the dialyzer comprises a dialysis fluid side and a patient effluent solution side, wherein the dialysis fluid side of dialyzer is configured to receive new dialysis fluid flowing in a first direction while the patient effluent solution side of dialyzer is configured to receive patient effluent solution in the opposite direction to maximize waste clearances.
  • 12. The disposable consumable container of claim 1, wherein the concentrate container includes acid powder, bicarb powder, and glucose.
  • 13. The disposable consumable container of claim 12, wherein the concentrate container further includes other concentrates configured to produce oncotic or osmotic gradient required for conducting peritoneal dialysis.
  • 14. The disposable consumable container of claim 12 wherein the concentrate container further includes other concentrates high molecular weight substances including polysaccharide, polyamides or polypeptides in order to minimize transfer of these substances into the patient.
CROSS REFERENCE TO RELATED APPLICATIONS

The present application is a continuation of U.S. patent application Ser. No. 16/325,664, filed Feb. 14, 2019, U.S. Pat. No. 11,534,537, titled “PERITONEAL DIALYSIS SYSTEM AND METHODS”, which is a national phase application under 35 USC 371 of International Patent No. PCT/US2017/047791, filed Aug. 21, 2017, titled “PERITONEAL DIALYSIS SYSTEM AND METHODS”, which claims priority under 35 USC 119 to U.S. Provisional Application No. 62/377,416, filed Aug. 19, 2016, titled “PERITONEAL DIALYSIS SYSTEM AND METHODS”, the disclosure of each of which is incorporated by reference in its entirety. All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.

US Referenced Citations (738)
Number Name Date Kind
1662870 Stancliffe Mar 1928 A
3356360 Ward Dec 1967 A
3695445 Esmond Oct 1972 A
3710237 Watson et al. Jan 1973 A
3762032 Bowling et al. Oct 1973 A
3809309 Batista May 1974 A
3827563 Boe et al. Aug 1974 A
3965008 Dawson Jun 1976 A
4080295 Riede Mar 1978 A
4089456 Toppen et al. May 1978 A
4100068 Jordan et al. Jul 1978 A
4110220 Lavender Aug 1978 A
4115273 Winstead Sep 1978 A
4155157 Gersbacher May 1979 A
4172033 Willock Oct 1979 A
4194014 Hermans et al. Mar 1980 A
4204628 Houston et al. May 1980 A
4209391 Lipps Jun 1980 A
4229299 Savitz et al. Oct 1980 A
4231366 Schael Nov 1980 A
4267040 Schal May 1981 A
4293409 Riede et al. Oct 1981 A
4310416 Tanaka et al. Jan 1982 A
4317725 Kume et al. Mar 1982 A
4342651 Ahrens Aug 1982 A
4476022 Doll Oct 1984 A
4486303 Brous Dec 1984 A
4500426 Ishii et al. Feb 1985 A
4508622 Polaschegg Apr 1985 A
4536201 Brorsson et al. Aug 1985 A
4560472 Granzow et al. Dec 1985 A
4624784 Lefebvre Nov 1986 A
4647748 Glassman Mar 1987 A
4661246 Ash Apr 1987 A
4689108 Barry, Jr. et al. Aug 1987 A
4711715 Polaschegg Dec 1987 A
4756835 Wilson Jul 1988 A
4769134 Allan et al. Sep 1988 A
4770787 Heath et al. Sep 1988 A
4773991 Aid Sep 1988 A
4786411 Benattar et al. Nov 1988 A
4827430 Aid et al. May 1989 A
4869421 Norris et al. Sep 1989 A
4875619 Anderson et al. Oct 1989 A
4889635 Chevallet Dec 1989 A
4894164 Polaschegg Jan 1990 A
4923613 Chevallet May 1990 A
4925056 McCoig May 1990 A
4940455 Guinn Jul 1990 A
5087930 Roy et al. Feb 1992 A
5092836 Polaschegg Mar 1992 A
5094749 Seita et al. Mar 1992 A
5120303 Hombrouckx Jun 1992 A
5147605 Tatsuno et al. Sep 1992 A
5227049 Chevallet et al. Jul 1993 A
5232145 Alley et al. Aug 1993 A
5236476 Klick Aug 1993 A
5247434 Peterson et al. Sep 1993 A
5259961 Eigendorf Nov 1993 A
5312550 Hester May 1994 A
5313023 Johnson May 1994 A
5316676 Drori May 1994 A
5326476 Grogan et al. Jul 1994 A
5336165 Twardowski Aug 1994 A
5342326 Peppel et al. Aug 1994 A
5344392 Senninger et al. Sep 1994 A
5346472 Keshaviah et al. Sep 1994 A
5360395 Utterberg Nov 1994 A
5385623 Diaz Jan 1995 A
5394732 Johnson et al. Mar 1995 A
5395351 Munsch Mar 1995 A
5401238 Pirazzoli Mar 1995 A
5409612 Maltais et al. Apr 1995 A
5421208 Packard et al. Jun 1995 A
5439451 Collinson et al. Aug 1995 A
5469264 Shigemori Nov 1995 A
5472614 Rossi Dec 1995 A
5489385 Raabe et al. Feb 1996 A
5498253 Aswad et al. Mar 1996 A
5498338 Kruger et al. Mar 1996 A
5503624 Roeher et al. Apr 1996 A
5520640 Utterberg May 1996 A
5526357 Jandrell Jun 1996 A
5533996 Murphey et al. Jul 1996 A
5534328 Ashmead et al. Jul 1996 A
5536258 Folden Jul 1996 A
5580460 Polaschegg Dec 1996 A
5580523 Bard Dec 1996 A
5582600 Loh Dec 1996 A
5591016 Kubota et al. Jan 1997 A
5591344 Kenley et al. Jan 1997 A
5593581 Lescoche Jan 1997 A
5595712 Harbster et al. Jan 1997 A
5609770 Zimmerman et al. Mar 1997 A
5610645 Moore et al. Mar 1997 A
5611214 Wegeng et al. Mar 1997 A
5613663 Schmidt et al. Mar 1997 A
5615996 Suzuki et al. Apr 1997 A
5618268 Raines et al. Apr 1997 A
5618441 Rosa et al. Apr 1997 A
5620608 Rosa et al. Apr 1997 A
5623969 Raines Apr 1997 A
5624572 Larson et al. Apr 1997 A
5629871 Love et al. May 1997 A
5630804 Imada et al. May 1997 A
5643190 Utterberg Jul 1997 A
5647984 Hovland et al. Jul 1997 A
5648684 Bertin et al. Jul 1997 A
5650071 Brugger et al. Jul 1997 A
5662144 Lo et al. Sep 1997 A
5685835 Brugger Nov 1997 A
5689966 Zess et al. Nov 1997 A
5693008 Brugger et al. Dec 1997 A
5698916 Eguchi Dec 1997 A
5711883 Folden et al. Jan 1998 A
5713850 Heilmann et al. Feb 1998 A
5725773 Polaschegg Mar 1998 A
5743892 Loh et al. Apr 1998 A
5744031 Bene Apr 1998 A
5749226 Bowman et al. May 1998 A
5769985 Kawakami et al. Jun 1998 A
5779833 Cawley et al. Jul 1998 A
5782575 Vincent et al. Jul 1998 A
5788099 Treu et al. Aug 1998 A
5788851 Kenley et al. Aug 1998 A
5792367 Mattisson et al. Aug 1998 A
5811062 Wegeng et al. Sep 1998 A
5813235 Peterson Sep 1998 A
5851202 Carlsson Dec 1998 A
5858238 Mcrea et al. Jan 1999 A
5858239 Kenley et al. Jan 1999 A
5861555 Hobro et al. Jan 1999 A
5868930 Kopf Feb 1999 A
5879316 Safar et al. Mar 1999 A
5881774 Utterberg Mar 1999 A
5885456 Charkoudian et al. Mar 1999 A
5895368 Utterberg Apr 1999 A
5903211 Flego et al. May 1999 A
5910138 Sperko et al. Jun 1999 A
5914033 Carlsson Jun 1999 A
5921678 Desai et al. Jul 1999 A
5928177 Brugger et al. Jul 1999 A
5928180 Krivitski et al. Jul 1999 A
5932103 Kenley et al. Aug 1999 A
5932940 Epstein et al. Aug 1999 A
5938634 Packard Aug 1999 A
5938938 Bosetto et al. Aug 1999 A
5951863 Kruger et al. Sep 1999 A
5951870 Utterberg Sep 1999 A
5957898 Jepson et al. Sep 1999 A
5974867 Forster et al. Nov 1999 A
5976115 Parris et al. Nov 1999 A
5983947 Utterberg Nov 1999 A
5984903 Nadal Nov 1999 A
5993174 Konishi Nov 1999 A
6003556 Brugger et al. Dec 1999 A
6010623 Schnell et al. Jan 2000 A
6024276 Hirata et al. Feb 2000 A
6032926 Fuchs Mar 2000 A
6036680 Horne et al. Mar 2000 A
6039877 Chevallet et al. Mar 2000 A
6041801 Gray et al. Mar 2000 A
6044691 Kenley et al. Apr 2000 A
6048432 Ecer Apr 2000 A
6058934 Sullivan May 2000 A
6064797 Crittendon et al. May 2000 A
6066261 Spickermann May 2000 A
6071269 Schnell et al. Jun 2000 A
6074559 Hahmann et al. Jun 2000 A
6077443 Goldau Jun 2000 A
6082891 Schubert et al. Jul 2000 A
6100463 Ladd et al. Aug 2000 A
6109994 Cho et al. Aug 2000 A
6113785 Miura et al. Sep 2000 A
6117115 Hill et al. Sep 2000 A
6117123 Barney et al. Sep 2000 A
6121539 Johnson et al. Sep 2000 A
6123798 Gandhi et al. Sep 2000 A
6126723 Drost et al. Oct 2000 A
6126831 Goldau et al. Oct 2000 A
6129973 Martin et al. Oct 2000 A
6132616 Twardowski et al. Oct 2000 A
6139754 Hartranft et al. Oct 2000 A
6142008 Cole et al. Nov 2000 A
6143181 Falkvall et al. Nov 2000 A
6143247 Sheppard et al. Nov 2000 A
6148635 Beebe et al. Nov 2000 A
6153102 Kenley et al. Nov 2000 A
6165149 Utterberg et al. Dec 2000 A
6165161 York et al. Dec 2000 A
6167910 Chow Jan 2001 B1
6187198 Utterberg Feb 2001 B1
6187199 Goldau Feb 2001 B1
6192596 Bennett et al. Feb 2001 B1
6193462 Kubota Feb 2001 B1
6202312 Rando Mar 2001 B1
6203522 Holmberg et al. Mar 2001 B1
6203535 Barney et al. Mar 2001 B1
6212333 Olk et al. Apr 2001 B1
6220299 Arvidsson et al. Apr 2001 B1
6221040 Kleinekofort Apr 2001 B1
6221064 Nadal Apr 2001 B1
6223130 Gray et al. Apr 2001 B1
6225497 Becker et al. May 2001 B1
6234773 Hill et al. May 2001 B1
6251279 Peterson et al. Jun 2001 B1
6254567 Treu et al. Jul 2001 B1
6254754 Ross et al. Jul 2001 B1
6258276 Mika et al. Jul 2001 B1
6261282 Jepson et al. Jul 2001 B1
6277277 Jacobi et al. Aug 2001 B1
6280406 Dolecek et al. Aug 2001 B1
6284141 Shaldon et al. Sep 2001 B1
6302653 Bryant et al. Oct 2001 B1
6308721 Bock et al. Oct 2001 B1
6309673 Duponchelle et al. Oct 2001 B1
6322551 Brugger Nov 2001 B1
6323662 Ferri Nov 2001 B2
6325774 Bene et al. Dec 2001 B1
6329139 Nova et al. Dec 2001 B1
6331252 El Sayyid et al. Dec 2001 B1
6334301 Otsap et al. Jan 2002 B1
6343614 Gray et al. Feb 2002 B1
6344033 Jepson et al. Feb 2002 B1
6346084 Schnell et al. Feb 2002 B1
6347711 Goebel et al. Feb 2002 B1
6349170 Fressinet et al. Feb 2002 B1
6350260 Goebel et al. Feb 2002 B1
6355161 Shah et al. Mar 2002 B1
6357332 Vecchio Mar 2002 B1
6365041 Hoadley Apr 2002 B1
6368505 Grummert et al. Apr 2002 B1
6375871 Bentsen et al. Apr 2002 B1
6382923 Gray May 2002 B1
6387069 Utterberg May 2002 B1
6395180 Chioini et al. May 2002 B2
6415860 Kelly et al. Jul 2002 B1
6416293 Bouchard et al. Jul 2002 B1
6423022 Roeher et al. Jul 2002 B1
6432309 Fuke et al. Aug 2002 B1
6454736 Ludt et al. Sep 2002 B1
6454942 Shintani et al. Sep 2002 B1
6468056 Murakoshi Oct 2002 B1
6477058 Luebs et al. Nov 2002 B1
6481982 Yokomichi Nov 2002 B1
6485263 Bryant et al. Nov 2002 B1
6488842 Nagaoka Dec 2002 B2
6488872 Beebe et al. Dec 2002 B1
6503062 Gray et al. Jan 2003 B1
6514225 Utterberg et al. Feb 2003 B1
6514412 Insley et al. Feb 2003 B1
6526357 Soussan et al. Feb 2003 B1
6527728 Zhang Mar 2003 B2
6530262 Esser Mar 2003 B1
6536742 Lotz et al. Mar 2003 B2
6537506 Schwalbe et al. Mar 2003 B1
6544229 Danby et al. Apr 2003 B1
6546998 Oh et al. Apr 2003 B2
6554789 Brugger et al. Apr 2003 B1
6572576 Brugger et al. Jun 2003 B2
6572641 Brugger et al. Jun 2003 B2
6575927 Weitzel et al. Jun 2003 B1
6579241 Roeher Jun 2003 B2
6579253 Burbank et al. Jun 2003 B1
6581906 Pott et al. Jun 2003 B2
6582385 Burbank et al. Jun 2003 B2
6592558 Quah Jul 2003 B2
6601432 Ericson et al. Aug 2003 B1
6602424 Krämer et al. Aug 2003 B1
6604908 Bryant et al. Aug 2003 B1
6607644 Apffel, Jr. Aug 2003 B1
6607697 Müller Aug 2003 B1
6616877 Close et al. Sep 2003 B2
6616909 Tonkovich et al. Sep 2003 B1
6623860 Hu et al. Sep 2003 B2
6630068 Vinci Oct 2003 B1
6635226 Tso et al. Oct 2003 B1
6640611 Ericson et al. Nov 2003 B2
6649046 Chevallet Nov 2003 B2
6649063 Brugger et al. Nov 2003 B2
6652627 Tonkovich et al. Nov 2003 B1
6653841 Koerdt et al. Nov 2003 B1
6654660 Singh et al. Nov 2003 B1
6666840 Falkvall et al. Dec 2003 B1
6666909 Tegrotenhuis et al. Dec 2003 B1
6672502 Paul et al. Jan 2004 B1
6673311 Sotoyama et al. Jan 2004 B1
6676621 Menninger Jan 2004 B1
6676835 O'Connor et al. Jan 2004 B2
6684710 Chevallet et al. Feb 2004 B2
6685831 Dönig et al. Feb 2004 B2
6686946 Masuda et al. Feb 2004 B2
6688381 Pence et al. Feb 2004 B2
6695807 Bell et al. Feb 2004 B2
6716356 Collins et al. Apr 2004 B2
6730233 Pedrazzi May 2004 B2
6731216 Ho et al. May 2004 B2
6733676 Takai May 2004 B2
6736789 Spickermann May 2004 B1
6738052 Manke et al. May 2004 B1
6743193 Brugger et al. Jun 2004 B2
6744038 Wang et al. Jun 2004 B2
6746514 Bedingfield et al. Jun 2004 B2
6749814 Bergh et al. Jun 2004 B1
6767333 Müller et al. Jul 2004 B1
6775577 Crnkovich et al. Aug 2004 B2
6793831 Paul et al. Sep 2004 B1
6797056 David Sep 2004 B2
6804991 Balschat et al. Oct 2004 B2
6806947 Ekdahl et al. Oct 2004 B1
6811707 Rovatti et al. Nov 2004 B2
6814547 Childers et al. Nov 2004 B2
6814726 Lauer Nov 2004 B1
6814859 Koehler et al. Nov 2004 B2
6818179 Edgson et al. Nov 2004 B1
6821432 Metzner Nov 2004 B2
6827698 Kleinekofort Dec 2004 B1
6830693 Govoni et al. Dec 2004 B2
6838156 Neyer et al. Jan 2005 B1
6852231 Ivansons et al. Feb 2005 B2
6858137 Hahmann et al. Feb 2005 B2
6863867 Vanden Bussche et al. Mar 2005 B2
6868309 Begelman Mar 2005 B1
6869538 Yu et al. Mar 2005 B2
6871838 Raines et al. Mar 2005 B2
6877713 Gray et al. Apr 2005 B1
6878283 Thompson Apr 2005 B2
6880034 Manke et al. Apr 2005 B2
6881344 Vasta et al. Apr 2005 B2
6889556 Steger May 2005 B2
6892781 Mcherron et al. May 2005 B2
6903332 Weiss et al. Jun 2005 B2
6905479 Bouchard et al. Jun 2005 B1
6911262 Sallavanti et al. Jun 2005 B2
6913877 Chaplen et al. Jul 2005 B1
6929751 Bowman, Jr. et al. Aug 2005 B2
6936031 Caleffi Aug 2005 B2
6939111 Huitt et al. Sep 2005 B2
6939471 Gross et al. Sep 2005 B2
6952963 Delnevo Oct 2005 B2
6953323 Childers et al. Oct 2005 B2
6955655 Burbank et al. Oct 2005 B2
6967002 Edgson et al. Nov 2005 B1
6974301 Suzuki et al. Dec 2005 B2
6976964 Chevallet et al. Dec 2005 B2
6979309 Burbank et al. Dec 2005 B2
6981522 O'Connor et al. Jan 2006 B2
6986428 Hester et al. Jan 2006 B2
6989134 Tonkovich et al. Jan 2006 B2
6994829 Whyatt et al. Feb 2006 B2
7004924 Brugger et al. Feb 2006 B1
7014705 David Mar 2006 B2
7021148 Kuhn et al. Apr 2006 B2
7022098 Wariar et al. Apr 2006 B2
7029456 Ware et al. Apr 2006 B2
7033498 Wong Apr 2006 B2
7033539 Krensky et al. Apr 2006 B2
7040142 Burbank May 2006 B2
7044432 Beden et al. May 2006 B2
7044927 Mueller et al. May 2006 B2
7063512 Haesloop et al. Jun 2006 B2
7070589 Lolachi et al. Jul 2006 B2
7074191 Bosetto et al. Jul 2006 B2
7087033 Brugger et al. Aug 2006 B2
7087036 Busby et al. Aug 2006 B2
7094345 Gilbert et al. Aug 2006 B2
7112273 Weigel et al. Sep 2006 B2
7114701 Peppel Oct 2006 B2
7115206 Chevallet et al. Oct 2006 B2
7115228 Lundtveit et al. Oct 2006 B2
7118920 Brophy et al. Oct 2006 B2
7121815 Knuth et al. Oct 2006 B2
7122149 Li et al. Oct 2006 B2
7122156 Bergh et al. Oct 2006 B2
7125540 Wegeng et al. Oct 2006 B1
7131956 Pirazzoli et al. Nov 2006 B1
7147615 Wariar et al. Dec 2006 B2
7150815 Ashmead et al. Dec 2006 B2
7152469 Milleker et al. Dec 2006 B2
7163531 Seese et al. Jan 2007 B2
7166084 Utterberg Jan 2007 B2
7168334 Drott Jan 2007 B1
7170591 Ohishi et al. Jan 2007 B2
7175697 Neri Feb 2007 B2
7186342 Pirazzoli et al. Mar 2007 B2
7188151 Kumar et al. Mar 2007 B2
7211442 Gilbert et al. May 2007 B2
7214312 Brugger et al. May 2007 B2
7217108 Herwig et al. May 2007 B2
7217364 Lauer et al. May 2007 B2
7223262 Brehm et al. May 2007 B2
7223338 Duchamp et al. May 2007 B2
7232418 Neri et al. Jun 2007 B2
7238164 Childers et al. Jul 2007 B2
7247146 Tonelli et al. Jul 2007 B2
7279134 Chan et al. Oct 2007 B2
7291123 Baraldi et al. Nov 2007 B2
7306197 Parrino et al. Dec 2007 B2
7314061 Peppel Jan 2008 B2
7316780 Fendya et al. Jan 2008 B1
7337674 Burbank et al. Mar 2008 B2
7341568 Zhang Mar 2008 B2
7354426 Young Apr 2008 B2
7355685 Scibona et al. Apr 2008 B2
7378280 Quake et al. May 2008 B2
7381195 Mori et al. Jun 2008 B2
7393337 Tonelli et al. Jul 2008 B2
7402249 Ikeda Jul 2008 B2
7469716 Parrino et al. Dec 2008 B2
7470265 Brugger et al. Dec 2008 B2
7488301 Beden et al. Feb 2009 B2
7488447 Sternby Feb 2009 B2
7493824 Brucksch et al. Feb 2009 B2
7494590 Felding et al. Feb 2009 B2
7503908 Bartholomew Mar 2009 B2
7507380 Chang et al. Mar 2009 B2
7510545 Peppel Mar 2009 B2
7517332 Tonelli et al. Apr 2009 B2
7517387 Chevallet et al. Apr 2009 B2
7520919 Caleffi Apr 2009 B2
7537687 Toyoda et al. May 2009 B2
7544300 Brugger et al. Jun 2009 B2
7551043 Nguyen et al. Jun 2009 B2
7559911 Giannella Jul 2009 B2
7575562 Oishi et al. Aug 2009 B2
7575564 Childers Aug 2009 B2
7591449 Raines et al. Sep 2009 B2
7603907 Reiter et al. Oct 2009 B2
7615035 Peppel Nov 2009 B2
7618531 Sugioka et al. Nov 2009 B2
7622043 Sawada et al. Nov 2009 B2
7632470 Tabata et al. Dec 2009 B2
7647834 O'Mahony et al. Jan 2010 B2
7648474 Paolini et al. Jan 2010 B2
7648476 Bock et al. Jan 2010 B2
7648792 Kaschmitter et al. Jan 2010 B2
7656527 Scarpaci Feb 2010 B2
7661294 Dam Feb 2010 B2
7671974 O'Mahony et al. Mar 2010 B2
7682328 Han et al. Mar 2010 B2
7686778 Burbank et al. Mar 2010 B2
7699992 Sternby Apr 2010 B2
7708714 Connell et al. May 2010 B2
7713226 Ash et al. May 2010 B2
7726361 Bartholomew Jun 2010 B2
7727220 Wieslander et al. Jun 2010 B2
7744553 Kelly et al. Jun 2010 B2
7749184 Cavalcanti et al. Jul 2010 B2
7758082 Weigel et al. Jul 2010 B2
7758547 Tonelli et al. Jul 2010 B2
7771379 Treu Aug 2010 B2
7771380 Jönsson et al. Aug 2010 B2
7775986 Roeher et al. Aug 2010 B2
7776219 Brugger et al. Aug 2010 B2
7780848 Kim et al. Aug 2010 B2
7788038 Oshita et al. Aug 2010 B2
7790029 Dannenmaier et al. Sep 2010 B2
7794141 Perry et al. Sep 2010 B2
7794419 Paolini et al. Sep 2010 B2
7801746 Moll et al. Sep 2010 B2
7815852 Sternby Oct 2010 B2
7824354 Vinci et al. Nov 2010 B2
7871390 Rambod et al. Jan 2011 B2
7873489 Dolgos et al. Jan 2011 B2
7896831 Sternby et al. Mar 2011 B2
7901579 Brugger et al. Mar 2011 B2
7913751 Zwittig Mar 2011 B2
7918993 Harraway Apr 2011 B2
7922899 Vasta et al. Apr 2011 B2
7955504 Jovanovic et al. Jun 2011 B1
7968250 Kaschmitter et al. Jun 2011 B2
8002727 Brugger et al. Aug 2011 B2
8012114 Daniel et al. Sep 2011 B2
8075509 Molducci et al. Dec 2011 B2
8105256 Ariza Jan 2012 B1
8105265 Demers et al. Jan 2012 B2
8105266 Childers et al. Jan 2012 B2
8128822 Browning et al. Mar 2012 B2
8137554 Jovanovic et al. Mar 2012 B2
8182440 Cruz et al. May 2012 B2
8182691 Stahl May 2012 B2
8190651 Treu et al. May 2012 B2
8192387 Brugger et al. Jun 2012 B2
8210049 Brugger Jul 2012 B2
8235931 Burbank et al. Aug 2012 B2
8236599 Chang et al. Aug 2012 B2
8267881 O'Mahony et al. Sep 2012 B2
8273245 Jovanovic et al. Sep 2012 B2
8293113 Jönsson et al. Oct 2012 B2
8293114 Jönsson et al. Oct 2012 B2
8298427 Ficheux et al. Oct 2012 B2
8323492 Childers et al. Dec 2012 B2
8329030 Childers et al. Dec 2012 B2
8343085 Toyoda et al. Jan 2013 B2
8394046 Nuernberger et al. Mar 2013 B2
8414182 Paul et al. Apr 2013 B2
8419945 Browning et al. Apr 2013 B2
8425471 Grant et al. Apr 2013 B2
8449487 Hovland et al. May 2013 B2
8460228 Burbank et al. Jun 2013 B2
8475398 O'Mahony Jul 2013 B2
8491518 Schnell et al. Jul 2013 B2
8496824 Remkes et al. Jul 2013 B2
8501009 Peterson et al. Aug 2013 B2
8506536 Schnell Aug 2013 B2
8512553 Cicchello et al. Aug 2013 B2
8512554 Yu et al. Aug 2013 B2
8524086 Peterson et al. Sep 2013 B2
8529491 Beiriger Sep 2013 B2
8535525 Heyes et al. Sep 2013 B2
8603020 Roger et al. Dec 2013 B2
8608658 Burbank et al. Dec 2013 B2
8647290 Masala et al. Feb 2014 B2
8679348 Burbank et al. Mar 2014 B2
8685244 Heyes et al. Apr 2014 B2
8685251 Smejtek et al. Apr 2014 B2
8753515 Curtis et al. Jun 2014 B2
8801922 Wrazel et al. Aug 2014 B2
8840581 McGill et al. Sep 2014 B2
9024746 Burbank et al. May 2015 B2
9097370 Schnell et al. Aug 2015 B2
9138687 Peterson et al. Sep 2015 B2
9220825 Buckberry Dec 2015 B2
9220828 Coates Dec 2015 B2
9283320 Brugger et al. Mar 2016 B2
9328969 Wrazel et al. May 2016 B2
9402945 Hogard et al. Aug 2016 B2
9480455 Buckberry Nov 2016 B2
9482218 Coates et al. Nov 2016 B2
9504777 Hogard et al. Nov 2016 B2
9526822 Meyer et al. Dec 2016 B2
9545469 Curtis et al. Jan 2017 B2
9579440 Hogard et al. Feb 2017 B2
9592029 Buckberry Mar 2017 B2
9636444 Burbank et al. May 2017 B2
9700663 Burbank et al. Jul 2017 B2
9835509 Brugger et al. Dec 2017 B2
9879807 Brugger et al. Jan 2018 B2
9895480 Wrazel et al. Feb 2018 B2
10105476 Peterson et al. Oct 2018 B2
10155076 Merchant Dec 2018 B2
10668201 Wrazel et al. Jun 2020 B2
11305040 Hogard et al. Apr 2022 B2
11534537 Ritson et al. Dec 2022 B2
20020023879 Hadden Feb 2002 A1
20020032398 Steele et al. Mar 2002 A1
20020088751 Rosenqvist et al. Jul 2002 A1
20020108859 Wang et al. Aug 2002 A1
20020108869 Savichenko Aug 2002 A1
20020115200 Zou et al. Aug 2002 A1
20020162784 Kohlheb et al. Nov 2002 A1
20020187069 Levin et al. Dec 2002 A1
20030010717 Brugger et al. Jan 2003 A1
20030039169 Ehrfeld et al. Feb 2003 A1
20030052429 Vigna et al. Mar 2003 A1
20030082066 Hajaligol et al. May 2003 A1
20030138349 Robinson et al. Jul 2003 A1
20030156991 Halas et al. Aug 2003 A1
20030163077 Kim et al. Aug 2003 A1
20030183345 Soberay Oct 2003 A1
20030220598 Busby et al. Nov 2003 A1
20040004589 Shih Jan 2004 A1
20040008370 Keane et al. Jan 2004 A1
20040012122 Nagaoka et al. Jan 2004 A1
20040016700 Kellam et al. Jan 2004 A1
20040020286 Blakley et al. Feb 2004 A1
20040022691 Allen et al. Feb 2004 A1
20040035452 Ma Feb 2004 A1
20040035462 McCarty et al. Feb 2004 A1
20040072278 Chou et al. Apr 2004 A1
20040082903 Micheli Apr 2004 A1
20040084370 Singh et al. May 2004 A1
20040084371 Kellam et al. May 2004 A1
20040086427 Childers et al. May 2004 A1
20040125689 Ehrfeld et al. Jul 2004 A1
20040157096 Peterson Aug 2004 A1
20040158189 Tonelli et al. Aug 2004 A1
20040208751 Lazar et al. Oct 2004 A1
20040215129 Edgson et al. Oct 2004 A1
20040256230 Yager et al. Dec 2004 A1
20050006296 Sullivan et al. Jan 2005 A1
20050007748 Callahan et al. Jan 2005 A1
20050040110 Felding Feb 2005 A1
20050070837 Ferrarini et al. Mar 2005 A1
20050074834 Chaplen et al. Apr 2005 A1
20050082225 Kreymann Apr 2005 A1
20050126211 Drost et al. Jun 2005 A1
20050129580 Swinehart et al. Jun 2005 A1
20050131332 Kelly et al. Jun 2005 A1
20050145497 Gilbert et al. Jul 2005 A1
20050179748 Malik et al. Aug 2005 A1
20050202557 Borenstein et al. Sep 2005 A1
20060046113 Wang et al. Mar 2006 A1
20060079698 Joshi et al. Apr 2006 A1
20060157413 Bene et al. Jul 2006 A1
20060174715 Wehrs et al. Aug 2006 A1
20060200064 Gross et al. Sep 2006 A1
20060266692 Foster et al. Nov 2006 A1
20070020400 Chang Jan 2007 A1
20070029365 Paul et al. Feb 2007 A1
20070119771 Schukar et al. May 2007 A1
20070125489 Paul et al. Jun 2007 A1
20070128707 Rorrer et al. Jun 2007 A1
20070131403 Vetrovec et al. Jun 2007 A1
20070149914 Axelsson et al. Jun 2007 A1
20070158249 Ash Jul 2007 A1
20070158268 Decomo Jul 2007 A1
20070184576 Chang et al. Aug 2007 A1
20070215644 Otis et al. Sep 2007 A1
20070243990 Kolenbrander et al. Oct 2007 A1
20070278155 Lo et al. Dec 2007 A1
20070295651 Martinez et al. Dec 2007 A1
20080006040 Peterson et al. Jan 2008 A1
20080009780 Leonard et al. Jan 2008 A1
20080053842 Williams et al. Mar 2008 A1
20080097274 Neri et al. Apr 2008 A1
20080108122 Paul et al. May 2008 A1
20080108930 Weitzel et al. May 2008 A1
20080149563 Ast Jun 2008 A1
20080196725 Mele Aug 2008 A1
20080200858 Ichiishi et al. Aug 2008 A1
20080296226 Gotch Dec 2008 A1
20090008331 Wilt et al. Jan 2009 A1
20090012452 Slepicka et al. Jan 2009 A1
20090038393 Chaung et al. Feb 2009 A1
20090076433 Folden et al. Mar 2009 A1
20090087326 Voltenburg et al. Apr 2009 A1
20090092526 Miller Apr 2009 A1
20090095679 Demers et al. Apr 2009 A1
20090101549 Kamen et al. Apr 2009 A1
20090101576 Rohde et al. Apr 2009 A1
20090114595 Wallenas et al. May 2009 A1
20090124963 Hogard et al. May 2009 A1
20090165366 Jovanovic et al. Jul 2009 A1
20090211977 Miller Aug 2009 A1
20090230036 Apel et al. Sep 2009 A1
20090306573 Gagner et al. Dec 2009 A1
20090309835 Levin et al. Dec 2009 A1
20090312686 Sakamoto et al. Dec 2009 A1
20090320684 Weaver et al. Dec 2009 A1
20100018923 Rohde et al. Jan 2010 A1
20100022934 Hogard Jan 2010 A1
20100051552 Rohde et al. Mar 2010 A1
20100078385 Kawarabata et al. Apr 2010 A1
20100089807 Heyes et al. Apr 2010 A1
20100192686 Kamen et al. Aug 2010 A1
20100271296 Kopychev et al. Oct 2010 A1
20100292627 Caleffi et al. Nov 2010 A1
20100292657 Fontanazzi et al. Nov 2010 A1
20100292944 Howell et al. Nov 2010 A1
20100321046 Randall et al. Dec 2010 A1
20100326914 Drost et al. Dec 2010 A1
20110005986 Kelly et al. Jan 2011 A1
20110105979 Schlaeper et al. May 2011 A1
20110106466 Furmanski et al. May 2011 A1
20110132841 Rohde et al. Jun 2011 A1
20110186517 Hedmann et al. Aug 2011 A1
20110189048 Curtis et al. Aug 2011 A1
20110257579 Rossi et al. Oct 2011 A1
20110295175 Felder et al. Dec 2011 A1
20120029937 Neftel et al. Feb 2012 A1
20120065581 Childers et al. Mar 2012 A1
20120103902 Childers et al. May 2012 A1
20120116316 Schutz et al. May 2012 A1
20120138533 Curtis et al. Jun 2012 A1
20120204968 Fulkerson et al. Aug 2012 A1
20120226236 Fini et al. Sep 2012 A1
20120248017 Beiriger et al. Oct 2012 A1
20120267291 Coates Oct 2012 A1
20120292246 Jovanovic et al. Nov 2012 A1
20120298580 Gronau et al. Nov 2012 A1
20120318740 Ekdahl et al. Dec 2012 A1
20130018301 Weaver et al. Jan 2013 A1
20130020237 Wilt et al. Jan 2013 A1
20130030344 Gronau et al. Jan 2013 A1
20130037485 Wilt et al. Feb 2013 A1
20130056418 Kopperschmidt et al. Mar 2013 A1
20130056419 Curtis Mar 2013 A1
20130060233 O'Connor et al. Mar 2013 A1
20130146541 Weigel et al. Jun 2013 A1
20130180339 Brugger Jul 2013 A1
20130186829 Callan et al. Jul 2013 A1
20130206693 Thys Aug 2013 A2
20130213890 Kelly et al. Aug 2013 A1
20130267883 Medrano Oct 2013 A1
20130303962 Bernard Nov 2013 A1
20130303963 Breuch et al. Nov 2013 A1
20140014580 Ritter Jan 2014 A1
20140018727 Burbank et al. Jan 2014 A1
20140021111 Roger et al. Jan 2014 A1
20140069861 Browning et al. Mar 2014 A1
20140072288 Newell Mar 2014 A1
20140076058 Brugger et al. Mar 2014 A1
20140158589 Furuhashi et al. Jun 2014 A1
20140178215 Baxter et al. Jun 2014 A1
20140209540 Smejtek et al. Jul 2014 A1
20140276424 Davis et al. Sep 2014 A1
20140291243 Curtis et al. Oct 2014 A1
20140319035 Burbank et al. Oct 2014 A1
20150005699 Burbank et al. Jan 2015 A1
20150027951 Wallace et al. Jan 2015 A1
20150041377 Heyes Feb 2015 A1
20150076053 Higgitt et al. Mar 2015 A1
20150129481 Higgitt et al. May 2015 A1
20150196702 Burbank et al. Jul 2015 A1
20150204733 Newell et al. Jul 2015 A1
20150238676 Giordano et al. Aug 2015 A1
20150252800 Buckberry et al. Sep 2015 A1
20150267821 Brugger et al. Sep 2015 A1
20150306294 Jansson et al. Oct 2015 A1
20150314055 Hogard et al. Nov 2015 A1
20150343128 Hogard et al. Dec 2015 A1
20150354906 Miller Dec 2015 A1
20150359973 Onken et al. Dec 2015 A1
20160051739 Buckberry Feb 2016 A1
20160051743 Buckberry Feb 2016 A1
20160082172 Miller et al. Mar 2016 A1
20160084785 Buckberry Mar 2016 A1
20160106906 Buckberry Apr 2016 A1
20160199558 Buckberry Jul 2016 A1
20160325034 Wiktor et al. Nov 2016 A1
20170290970 Friederichs et al. Oct 2017 A1
20170296727 Burbank et al. Oct 2017 A1
20170296730 Soto et al. Oct 2017 A1
20170312419 Burbank et al. Nov 2017 A1
20170326285 Hogard et al. Nov 2017 A1
20180071447 Gronau et al. Mar 2018 A1
20180128688 Newell et al. May 2018 A1
20180128698 Brugger et al. May 2018 A1
20190022293 Peterson et al. Jan 2019 A1
20190201604 Hogard et al. Jul 2019 A1
20200061273 Hogard et al. Feb 2020 A1
20210069401 Peterson et al. Mar 2021 A1
20210244869 Hogard et al. Aug 2021 A1
20210252204 Hogard et al. Aug 2021 A1
20220040389 Hogard et al. Feb 2022 A1
20220143285 Hu et al. May 2022 A1
20220203004 Hu et al. Jun 2022 A1
Foreign Referenced Citations (65)
Number Date Country
2830085 Sep 2012 CA
2887068 Apr 2014 CA
2930431 May 2015 CA
200951223 Sep 2007 CN
8702995 Jun 1987 DE
69217519 Jun 1997 DE
0165751 Dec 1985 EP
0278100 Aug 1988 EP
0324922 Jul 1989 EP
0679100 Nov 1995 EP
0796997 Sep 1997 EP
0547025 Jun 2002 EP
1892000 Feb 2008 EP
1898000 Mar 2008 EP
2319551 May 2011 EP
2535067 Dec 2012 EP
1289738 Sep 1972 GB
59-58002 Apr 1984 JP
60-143803 Jul 1985 JP
H4-35669 Feb 1992 JP
H11-33111 Feb 1999 JP
2001510266 Jul 2001 JP
2002143298 May 2002 JP
2002527212 Aug 2002 JP
2003508179 Mar 2003 JP
2007167108 Jul 2007 JP
2007268490 Oct 2007 JP
2007529707 Oct 2007 JP
2007327950 Dec 2007 JP
2012152286 Aug 2012 JP
2012152288 Aug 2012 JP
55-14045 Jun 2014 JP
2014531922 Dec 2014 JP
2018524074 Aug 2018 JP
WO0016916 Mar 2000 WO
WO0025843 May 2000 WO
WO0057935 Oct 2000 WO
WO0240874 May 2002 WO
WO02076529 Oct 2002 WO
WO03076661 Sep 2003 WO
WO2006011009 Feb 2006 WO
WO2006039293 Apr 2006 WO
WO2007073739 Jul 2007 WO
WO2007089855 Aug 2007 WO
WO2008027967 Mar 2008 WO
WO2008106191 Sep 2008 WO
WO2010027435 Mar 2010 WO
WO2010062698 Jun 2010 WO
WO2010085764 Jul 2010 WO
WO2010146343 Dec 2010 WO
WO2013031966 Mar 2013 WO
WO2014117000 Jul 2014 WO
WO2014124180 Aug 2014 WO
WO2014159420 Oct 2014 WO
WO2014160370 Oct 2014 WO
WO2015150179 Oct 2015 WO
WO2015173151 Nov 2015 WO
WO2015185920 Dec 2015 WO
WO2016030147 Mar 2016 WO
WO2016049542 Mar 2016 WO
WO2016057981 Apr 2016 WO
WO2016057982 Apr 2016 WO
WO2016130679 Sep 2016 WO
WO2017072511 May 2017 WO
WO2018035520 Feb 2018 WO
Non-Patent Literature Citations (25)
Entry
Allis et al., “Chapter 16: Nanostructural Architectures from Molecular Building Blocks,” in Handbook of Nanoscience, Engineering, and Technology, 1st Edition (Electrical Engineering Handbook), CRC Press LLC, Boca Raton, FL, Chapter 16 (70 pgs.), Oct. 2002.
Anglés et al., “Plasticized starch/Tunicin Whiskers Nanocomposite Materials. 2. Mechanical behavior,” Macromolecules, 34, pp. 2921-2931, Mar. 2001.
California Energy Commission; Development of Supported Polymeric Liquid Membrane Technology for Aqueous MTBE Mitigation, EPRI, Palo Alto, CA, California Energy Commission, Sacramento, CA: Doc. No. 1006577; 70 pgs.; Jul. 2002.
Demura et al., “Ductile Thin Foll of Ni3Al,” Mechanical Properties of Structural Films, ASTM International Nov. 2000 Symposium (Orlando, FL), pp. 248-261, published Oct. 1, 2001.
Favier et al.; Nanocomposite materials from latex and cellulose whiskers; Polymers for Advanced Technologies; 6; pp. 351-355; Jan. 1995.
Federal Energy Technology Center, “Technology Development Through Industrial Partnerships,” (Tech. Dev. Data Sheet), 12 pgs., Sep. 1998.
Grunert et al., “Progress in the Development of Cellulose Reinforced Nanocomposites,” PMSE Preprints 2000, 82, 232, 2 pgs., Mar. 2000.
Haas, “Further development of MMW and SMMW platelet feed horn arrays,” Astron. Soc. Pac. Conf. Ser., vol. 75, pp. 99-105, Multi-Feed Systems for Radio Telescopes, Workshop held in Tucson, Arizona, May 16-18, 1994.
Introtek International; Drip chamber liquid level sensor (sales literature); 2 pages; retrieved from the internet (http://www.introtek.com/PDFs/1/DDS-14.0_DripDetectSensor.pdf); © Jan. 1, 2009.
Koeneman et al., “Feasibility of Micro Power Supplies for MEMS,” (pre-publication copy) J. MicroElectoMechanical Sys., 6(4), pp. 355-362, Dec. 1997.
Morin et al., “Nanocomposites of Chitin Whiskers from Riftia Tubes and Poly (caprolactone),” Macromolecules, vol. 35, pp. 2190-2199, Feb. 2002.
Nakamura et al., “Research on Pressure Welding Conditions of Various Work Metals (Effects of Contact Pressure, Surface Expansion Ratio and Temperature),” JSME International Journal, Series III 31(3), 612-617, Sep. 1988.
Nakao et al., “Diffusion Bonding of Intermetallic Compound TiAl,” ISIJ International, 31(10), 1260-1266, Oct. 1991.
Oddy et al., “Electrokinetic Instability Micromixing,” Anal. Chem., 73(24), pp. 5822-5832, Dec. 2001.
Omega Engineering Inc.; Load Cell (definition, information); 3 pgs; retrieved from the internet on Jun. 17, 2015 (http://www.omega.com/prodinfo/LoadCells.html).
Orts et al., “Effect of Fiber Source on Cellulose Reinforced Polymer Nanocomposites,” ANTEC 2004: Conference Proceedings, 62nd Annual Tech. Conference; Chicago, IL, pp. 2427-2431, May 2004.
Paillet et al., “Chitin Whisker Reinforced Thermoplastic Nanocomposites,” Macromolecules, vol. 34, No. 19, pp. 6527-6530, Sep. 2001.
Paul et al., “Microlamination for Microtechnology-based Energy, Chemical, and Biological Systems,” ASME IMECE, ASE vol. 39, pp. 45-52, Nashville, Tennessee, Nov. 15-20, 1999.
Pluess, “Application of Controlled Thermal Expansion in Diffusion Bonding for the High-Volume Microlamination of MECS Devices,” Thesis (MS), Oregon State University, 193 pgs., Sep. 2004.
Porter et al.; Cost drivers in microlamination based on a high volume production system design; ASME 2002 Conf. Proc.; New Orleans, Louisiana; pp. 267-274; Nov. 17-22, 2002.
Sharma et al., “The Application of Surface Mount Technology to Multi-Scale Process Intensification,” ASPE, pp. 1-4, Oct. 2003.
Stroock et al., “Chaotic Mixer for Microchannels,” Science, 295, pp. 647-651, Jan. 2002.
Thorsen et al.; Microfluidic Large-Scale Integration; Science; 298; pp. 580-584; Oct. 18, 2002.
Wegeng et al., “Chemical system miniaturization,” Proceedings of the AlChE Spring National Meeting, pp. 1-13, Feb. 1996.
Peterson et al.; U.S. Appl. No. 18/344,376 entitled “Fluid Purification System,” filed Jun. 29, 2023.
Related Publications (1)
Number Date Country
20230347035 A1 Nov 2023 US
Provisional Applications (1)
Number Date Country
62377416 Aug 2016 US
Continuations (1)
Number Date Country
Parent 16325664 US
Child 18059181 US